Alpha Cognition (ACOG) Interest Expenses (2023 - 2025)
Alpha Cognition's (ACOG) quarterly Interest Expenses came in at $72912.0 in Q4 2025, up 184.66% year-on-year from $25613.4 in Q4 2024, and down 96.88% quarter-over-quarter from $2.3 million in Q3 2025.
Alpha Cognition (ACOG) Interest Expenses (2023 - 2025) Analysis & Trends
Alpha Cognition's Interest Expenses history runs 3 years deep, the most recent figure standing at $72912.0 for Q4 2025.
- On a quarterly basis, Interest Expenses rose 184.66% year-over-year to $72912.0 in Q4 2025; TTM through Dec 2025 was $20920.0, a 149.36% increase from a year earlier, with the FY2025 full-year figure at $19.9 million, up 22.78% from the prior year.
- Interest Expenses slipped to $72912.0 in Q4 2025 per ACOG's latest filing, from $2.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $8.3 million in Q2 2025 and bottomed at -$86120.0 in Q4 2024.
- The 3-year median for Interest Expenses is $72912.0 (2025), against an average of $2.3 million.
- Biggest YoY gain for Interest Expenses was 452571.75% in 2024; the steepest drop was 591.66% in 2024.
- Year by year, Interest Expenses stood at $17516.0 in 2023, then plunged by 591.66% to -$86120.0 in 2024, then jumped by 184.66% to $72912.0 in 2025.
- Per Business Quant, the three latest ACOG Interest Expenses figures stand at $72912.0 (Q4 2025), $2.3 million (Q3 2025), and $8.3 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Alpha Cognition | 147.81 Mn | 81.70 Mn | 2.61 Mn | 72,912.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72,912.00 |
| Dec 31, 2025 | 72,912.00 |
| Sep 30, 2025 | 2.34 Mn |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 8.34 Mn |
| Jun 30, 2025 | 8.34 Mn |
| Mar 31, 2025 | 725,617.00 |
| Mar 31, 2025 | 725,617.00 |
| Dec 31, 2024 | -86,120.00 |
| Dec 31, 2024 | -86,120.00 |
| Sep 30, 2024 | 6.94 Mn |
| Sep 30, 2024 | 6.94 Mn |
| Jun 30, 2024 | 6.94 Mn |
| Jun 30, 2024 | 6.94 Mn |
| Mar 31, 2024 | 16,612.00 |
| Mar 31, 2024 | 16,612.00 |
| Dec 31, 2023 | 17,516.00 |
| Dec 31, 2023 | 17,516.00 |
| Sep 30, 2023 | 9,607.00 |
| Sep 30, 2023 | 9,607.00 |